Emerging therapy targeting tyrosine-protein kinase BTK: potential for ibrutinib and other BTK inhibitors

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)569
Number of pages1
JournalDrugs of the Future
Volume38
Issue number8
Publication statusPublished - 2013

Cite this